These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26661392)

  • 1. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection.
    Brumley PE; Malani AN; Kabara JJ; Pisani J; Collins CD
    J Antimicrob Chemother; 2016 Mar; 71(3):836-40. PubMed ID: 26661392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an antimicrobial stewardship intervention on outcomes for patients with Clostridium difficile infection.
    Welch HK; Nagel JL; Patel TS; Gandhi TN; Chen B; De Leon J; Chenoweth CE; Washer LL; Rao K; Eschenauer GA
    Am J Infect Control; 2016 Dec; 44(12):1539-1543. PubMed ID: 27592160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
    Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
    J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study.
    Nguyen CT; Gandhi T; Chenoweth C; Lassiter J; Dela Pena J; Eschenauer G; Nagel JL
    J Antimicrob Chemother; 2015 Dec; 70(12):3390-6. PubMed ID: 26338049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
    Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
    Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tipping point: patients predisposed to Clostridium difficile infection and a hospital antimicrobial stewardship programme.
    Stites SD; Cooblall CA; Aronovitz J; Singletary SB; Micklow K; Sjeime M
    J Hosp Infect; 2016 Nov; 94(3):242-248. PubMed ID: 27742079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia.
    Foolad F; Huang AM; Nguyen CT; Colyer L; Lim M; Grieger J; Li J; Revolinski S; Mack M; Gandhi T; Wainaina JN; Eschenauer G; Patel TS; Marshall VD; Nagel J
    J Antimicrob Chemother; 2018 May; 73(5):1402-1407. PubMed ID: 29462306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial stewardship programs that target only high-cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infections.
    Bui C; Zhu E; Donnelley MA; Wilson MD; Morita M; Cohen SH; Brown J
    Am J Infect Control; 2016 Dec; 44(12):1684-1686. PubMed ID: 27908435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
    Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
    J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.
    Lew KY; Ng TM; Tan M; Tan SH; Lew EL; Ling LM; Ang B; Lye D; Teng CB
    J Antimicrob Chemother; 2015 Apr; 70(4):1219-25. PubMed ID: 25473028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical antimicrobial prescriptions in patients with Clostridium difficile infection at hospital admission and impact on clinical outcome.
    Pop-Vicas A; Shaban E; Letourneau C; Pechie A
    Infect Control Hosp Epidemiol; 2012 Nov; 33(11):1101-6. PubMed ID: 23041807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
    Shea KM; Hobbs ALV; Jaso TC; Bissett JD; Cruz CM; Douglass ET; Garey KW
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antimicrobial stewardship interventions on Clostridium difficile infection and clinical outcomes: segmented regression analyses.
    Patton A; Davey P; Harbarth S; Nathwani D; Sneddon J; Marwick CA
    J Antimicrob Chemother; 2018 Feb; 73(2):517-526. PubMed ID: 29177477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic policies in acute English NHS trusts: implementation of 'Start Smart-Then Focus' and relationship with Clostridium difficile infection rates.
    Llewelyn MJ; Hand K; Hopkins S; Walker AS
    J Antimicrob Chemother; 2015 Apr; 70(4):1230-5. PubMed ID: 25538165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program.
    Chopra T; Neelakanta A; Dombecki C; Awali RA; Sharma S; Kaye KS; Patel P
    Am J Infect Control; 2015 Apr; 43(4):314-7. PubMed ID: 25838133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
    Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
    Chia BY; Teo JQ; Lee W; Liew YX; Ee RP; Chlebicki MP; Oon LL; Kwa AL
    J Glob Antimicrob Resist; 2019 Jun; 17():312-315. PubMed ID: 30682564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.